Active surveillance and racial difference in risk

Posted on March 12, 2013 by Sitemaster

A new article in Urology (“the Gold journal”) suggests that African American men diagnosed with low-risk forms of prostate cancer may need to meet more stringent criteria than Caucasian Americans if they are to be appropriately managed on active surveillance protocols. Why? Because they appear to be at higher risk for disease progression. … READ MORE …

Filed under: Diagnosis, Management, Living with Prostate Cancer, Treatment, Risk | Tagged: , , , , , , | 1 Comment »

Counseling and support associated with active surveillance: highly necessary for some

Posted on March 4, 2013 by Sitemaster

It is well understood that some (perhaps even many) men diagnosed with low-risk disease have difficulty accepting active monitoring of any type as an effective and safe management strategy for deferring immediate, unnecessary treatment  — and perhaps being able to avoid treatment at all. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: , , , , | 7 Comments »

National Proactive Surveillance Network goes live in Baltimore and Los Angeles

Posted on October 24, 2012 by Sitemaster

As reported previously, in May 2010, the Prostate Cancer Foundation, in association with Johns Hopkins and the Cedars-Sinai Medical Center announced their intention to develop a national initiative to track the management of men with prostate cancer using active monitoring  (“active surveillance”) as opposed to invasive treatment. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: , , , , , | 5 Comments »

Speciality bias still affecting treatment recommendations for low-risk prostate cancer?

Posted on October 16, 2012 by Sitemaster

A majority of urologists and radiation oncologists are still not recommending active monitoring (“active surveillance”) as a first-line method for the management of patients with low-risk prostate cancer. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , | 10 Comments »

All the PIVOT trial hype from Europe

Posted on April 30, 2012 by Sitemaster

There has been a lot of media hype in Europe around the re-presentation of the PIVOT data by Dr. Wilt at the annual meeting of the European Association of Urology in Paris last week. And yet every prostate cancer specialist attending that meeting must have already been well aware of these data. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , , | 8 Comments »

Are we (still) over-treating older men with localized prostate cancer?

Posted on March 15, 2011 by Sitemaster

There is good reason to believe that a very high percentage of older men — particularly those over 75 years with low-risk prostate cancer who have a life expectancy of 10 years or less — will get little to no clinical or survival benefit from active therapeutic intervention (although they should clearly be carefully monitored and given all appropriate care). … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Risk, Treatment | Tagged: , , , , | 2 Comments »

Thursday news update, Part A: October 30, 2008

Posted on October 30, 2008 by Sitemaster

There’s a lot of news today, so we will break it into two sections for reading convenience. In Part A, we deal with information about:

  • Physicial activity and prostate cancer risk
  • Vasectomy and prostate cancer risk
  • The use of surveillance and watchful waiting in men in Sweden
  • A modification to Walsh’s nerve-sparing radical prostatectomy
  • The risks of “multimodal” therapy in high-risk patients and
  • A new, long-acting form of testosterone therapy … READ MORE …

Filed under: Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment, Uncategorized | Tagged: , , , , , , , | Leave a Comment »

Three important editorials

Posted on September 17, 2008 by Sitemaster

The October issue of the Journal of Urology carries three editorials that we consider to be very important to the world of prostate cancer — for professionals and patients alike. … READ MORE …

Filed under: Diagnosis, Management, Treatment | Tagged: , , , , , | 3 Comments »

Your news update: Tuesday, September 16

Posted on September 16, 2008 by Sitemaster

Today’s news is focused on issues around prevention, screening, and active surveillance:

  • The potential cost-effectiveness of widespread use of finasteride to prevent prostate cancer
  • An update on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
  • The argument in favor of active surveillance as first-line management for men with low risk prostate cancer … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention | Tagged: , , , , | Leave a Comment »

Prostate cancer news update: Tuesday, August 26

Posted on August 26, 2008 by Sitemaster

There are several interesting news items today, as follows:

  • Ethnic variation in the performance of PSA and PSA density as markers for risk of prostate cancer
  • Potential underuse of active surveillance in eligible patients
  • Application of active surveillance in a 40-patient case series
  • The potential to eliminate the need for a urethral (Foley) catheter post-surgery
  • Circulating tumor cell levels as a predictor for response to androgen deprivation therapy … READ MORE …

Filed under: Diagnosis, Management, Treatment, Uncategorized | Tagged: , , , , , , , , , , , , , | 1 Comment »

Follow

Get every new post delivered to your Inbox.

Join 828 other followers